SELLAS Life Sciences (SLS) Change in Account Payables (2019 - 2024)
Historic Change in Account Payables for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to -$1.8 million.
- SELLAS Life Sciences' Change in Account Payables fell 39174.92% to -$1.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $297000.0, marking a year-over-year decrease of 8657.93%. This contributed to the annual value of -$2.1 million for FY2024, which is 19295.96% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Change in Account Payables stood at -$1.8 million, which was down 39174.92% from -$1.1 million recorded in Q2 2024.
- SELLAS Life Sciences' Change in Account Payables' 5-year high stood at $1.8 million during Q1 2024, with a 5-year trough of -$1.8 million in Q3 2024.
- Over the past 5 years, SELLAS Life Sciences' median Change in Account Payables value was -$173000.0 (recorded in 2020), while the average stood at -$45052.6.
- As far as peak fluctuations go, SELLAS Life Sciences' Change in Account Payables crashed by 189722.22% in 2020, and later skyrocketed by 73591.55% in 2024.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Change in Account Payables stood at $1.3 million in 2020, then tumbled by 131.16% to -$401000.0 in 2021, then skyrocketed by 406.73% to $1.2 million in 2022, then increased by 7.15% to $1.3 million in 2023, then tumbled by 234.14% to -$1.8 million in 2024.
- Its Change in Account Payables stands at -$1.8 million for Q3 2024, versus -$1.1 million for Q2 2024 and $1.8 million for Q1 2024.